Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Photocure ASA : Mandatory notification of trade

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/22/2013 | 11:02am CEST
Photocure ASA - Selling price of shares

Reference is made to the statement dated 15.03.2013. The payment has been determined based on a selling price of NOK 40.2584 per share.

After exercising options, Grete Hogstad holds 8 750 unexercised options in the Company, corresponding to 8 750 shares at the strike price of NOK 20.30. In addition she holds; 7
200 unexercised options, corresponding to 7 200 shares at the strike price of NOK 32.00;
23 400 unexercised options, corresponding to 23 400 shares at the strike price of NOK
44.00; and 17 250 unexercised options, corresponding to 17 250 shares at the strike price of NOK 50.75. After completion of the abovementioned transactions, the primary insider holds 10 500 shares in the Company.
After exercising options, Gry Stensrud holds 6 250 unexercised options in the Company, corresponding to 6 250 shares at the strike price of 20.30. In addition she holds; 19 050 unexercised options, corresponding to 19 050 shares at the strike price of NOK 44.00; and 22 500 unexercised options, corresponding to 22 500 shares at the strike price of NOK 50.75. After completion of the abovementioned transactions, the primary insider holds 6 shares in the Company.

For further information, please contact: Photocure

CFO Erik Dahl
Tel: +47 450 55 000, Email: ed@photocure.no

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PHOTOCURE ASA
09:35a PHOTOCURE : Disclosure of shareholding
07/17 PHOTOCURE ASA : Update on medicare reimbursement for blue light cystoscopy with ..
05/26 PHOTOCURE : Jeremy Bahr appointed Chief Business Officer
05/26 PHOTOCURE : Appoints Three New Members to its Board of Directors
05/23 PHOTOCURE ASA : Results for the first quarter of 2017
05/18PHOTOCURE ASA : quaterly earnings release
05/16 PHOTOCURE ASA : Presentation of the first quarter 2017 results and the results f..
05/15 PHOTOCURE : Positive data from Phase 3 US Blue Light Cystoscopy with Cysview® st..
05/12 PHOTOCURE ASA : Phase 3 study investigating Blue Light Flexible Cystoscopy with ..
05/08PHOTOCURE ASA : quaterly earnings release
More news
News from SeekingAlpha
05/24 PhotoCure ASA (PHCUF) Updates on Bladder Cancer - Slideshow
05/24 PhotoCure ASA (PHCUF) Updates on Bladder Cancer - Slideshow
Financials ( NOK)
Sales 2017 149 M
EBIT 2017 -44,3 M
Net income 2017 -32,7 M
Finance 2017 117 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018 116,28
EV / Sales 2017 2,83x
EV / Sales 2018 1,94x
Capitalization 539 M
Chart PHOTOCURE ASA
Duration : Period :
Photocure ASA Technical Analysis Chart | PHO | NO0010000045 | 4-Traders
Technical analysis trends PHOTOCURE ASA
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Average target price 36,0  NOK
Spread / Average Target 44%
EPS Revisions
Managers
NameTitle
Kjetil Hestdal President, Chief Executive Officer & Media Contact
Jan Hendrik Egberts Chairman
Erik Dahl Chief Financial Officer & IR Contact
Inger Ferner Heglund Vice President-Research & Development
Xavier Denis Yon Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PHOTOCURE ASA-37.14%67
JOHNSON & JOHNSON14.47%355 263
NOVARTIS7.35%220 651
ROCHE HOLDING LTD.4.30%220 599
PFIZER1.91%197 115
MERCK AND COMPANY5.93%170 565